As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes
Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR
The IC50 value of truncated Ex4 is 0.6 nM compared to 1.0 nM for Ex4 and 1.6 nM for GLP-1 (Runge et al., 2008)
Low-fat diet for long-term weight loss: A meta-analysis of randomised controlled trials
It is a safe and effective method for reducing localized fat deposits without the need for invasive procedures
Evidence-Based Complementary and Alternative Medicine , 2018 , 130